Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Common-Size Balance Sheet: Assets

Bristol-Myers Squibb Co., common-size consolidated balance sheet: assets

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Cash and cash equivalents 12.28 9.50 19.75 16.16 12.57
Marketable debt securities 1.08 2.34 5.64 4.15 6.27
Net trade receivables 6.09 4.98 13.25 12.96 11.20
Alliance, Royalties, VAT and other 1.08 0.93 3.18 3.76 3.39
Receivables 7.17% 5.91% 16.43% 16.72% 14.58%
Inventories 1.75 3.30 3.42 3.48 3.68
Prepaid and refundable income taxes 1.52 0.58 0.62 2.06 1.86
Research and development 0.42 0.32 0.96 0.00 0.00
Equity investments 0.52 0.00 0.00 0.00 0.00
Assets held-for-sale 0.00 0.00 1.37 0.00 0.00
Other 0.74 0.63 0.86 1.72 1.69
Other current assets 3.20% 1.53% 3.81% 3.78% 3.55%
Current assets 25.48% 22.59% 49.05% 44.27% 40.66%
Property, plant and equipment 4.97 4.81 14.37 14.91 14.77
Goodwill 17.34 17.31 18.69 20.46 20.40
Other intangible assets 44.94 49.23 3.12 3.61 4.11
Deferred income taxes 0.98 0.39 3.92 4.80 8.89
Marketable debt securities 0.37 0.59 5.07 7.39 8.07
Equity investments 3.44 2.62 1.93 0.00 0.00
Inventories 0.91 1.06 1.23 0.00 0.00
Operating lease right-of-use assets 0.73 0.54 0.00 0.00 0.00
Pension and postretirement 0.18 0.35 2.31 0.00 0.00
Restricted cash 0.29 0.30 0.00 0.00 0.00
Other 0.39 0.21 0.32 4.57 3.11
Other non-current assets 5.92% 5.08% 5.79% 4.57% 3.11%
Non-current assets 74.52% 77.41% 50.95% 55.73% 59.34%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Bristol-Myers Squibb Co. current assets as a percentage of total assets decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.
Property, plant and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Bristol-Myers Squibb Co. property, plant and equipment as a percentage of total assets decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Bristol-Myers Squibb Co. non-current assets as a percentage of total assets increased from 2018 to 2019 but then slightly decreased from 2019 to 2020.